Brain scan study to finally test if low serotonin causes depression
NCT ID NCT07651293
First seen Jun 24, 2026 · Last updated Jun 24, 2026
Summary
This study will test the long-standing theory that depression is caused by low serotonin levels in the brain. Researchers will give a single dose of fenfluramine (a drug that releases serotonin) to 46 people—half with depression and half healthy—and use PET brain scans to measure serotonin release. The goal is to see if people with depression have a weaker serotonin response, which could help explain why some antidepressants work and others don't.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
entre for Psychedelics Research, Division of Psychiatry Imperial College London, Level 2, Commonwealth Building, Hammersmith Campus, Du Cane Road, London
London, W120NN, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Fenfluramine hydrochloride (a serotonin-releasing drug)
What this could lead to
If successful, this study could clarify whether serotonin deficiency plays a key role in depression and help identify who might benefit from SSRI antidepressants.
What could go wrong
This is a small, early-stage observational study (46 people) that does not test a new treatment. Fenfluramine is used only as a probe, not as a therapy. Results may not apply broadly.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.